Calmare Therapeutics (CTTC)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 09-2000 | 07-2000 | 06-2000 | 04-2000 | 03-2000 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | N/A | 1,716 | 80 | N/A | 120 |
| Marketable Securities | N/A | 5,000 | 6,910 | N/A | 5,730 |
| Receivables | 2,420 | 2,420 | 1,050 | N/A | 2,200 |
| Other current assets | 150 | 0 | 80 | 0 | 110 |
| TOTAL | $2,570 | $9,286 | $8,120 | $N/A | $8,160 |
| Non-Current Assets | |||||
| PPE Net | N/A | 116 | N/A | N/A | N/A |
| Investments And Advances | 0 | 1,526 | 1,510 | 0 | 90 |
| Intangibles | 0 | 1,167 | 0 | 0 | 0 |
| Other Non-Current Assets | 1,160 | 0 | 1,230 | 0 | 1,230 |
| TOTAL | $1,160 | $2,808 | $2,740 | $N/A | $1,320 |
| Total Assets | $3,730 | $12,094 | $11,000 | $N/A | $9,630 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 0 | 65 | 90 | 0 | 90 |
| Accrued Expenses | N/A | 2,100 | 1,490 | N/A | 1,870 |
| TOTAL | $N/A | $2,166 | $1,590 | $N/A | $1,960 |
| Non-Current Liabilities | |||||
| TOTAL | $N/A | $N/A | $N/A | $N/A | $N/A |
| Total Liabilities | $N/A | $2,166 | $1,590 | $N/A | $1,960 |
| Shareholders' Equity | |||||
| Common Shares | N/A | 62 | 60 | N/A | 60 |
| Retained earnings | N/A | -17,248 | -17,680 | N/A | -18,260 |
| Other shareholders' equity | 60 | 0 | -10 | 0 | 0 |
| TOTAL | $60 | $9,928 | $9,410 | $N/A | $7,660 |
| Total Liabilities And Equity | $60 | $12,094 | $11,000 | $0 | $9,620 |